Brain Metastasis Group, CNIO
Madrid, Spain
Manuel Valiente, PhD, Junior Group Leader of the Brain Metastasis Group, Molecular Oncology Programme, CNIO, Madrid (Spain).
Dr. Valiente investigates the biology of brain metastasis in order to challenge this unmet clinical need.
Specifically, his laboratory studies novel brain metastasis mediators, characterizes the metastasis-associated microenvironment, designs better experimental models and explores novel methods to target brain metastasis. All these aims consider the brain environment as a critical component to understand the biology of this progression of cancer.
Dr. Valiente has co-founded the first National Network of Brain Metastasis (RENACER) in Spain, which is allowing his team to translate laboratory findings to clinical studies faster. In addition, he has established a large network of international clinical collaborators for the same purpose.
His contributions to brain metastasis research have been recognized with the ASPIRE Award, ERC CoG, EMBO YIP, CLIP Award, Beug Foundation’s Prize for Metastasis Research, Bristol-Myers Squibb-MRA Young Investigator Award among others.
He is the Chair of the Scientific Committee of the European Association of Neuro-Oncology (EANO), and Board Member of the Metastasis Research Society (MRS) and ESMO faculty member (CNS Tumours faculty group).